Marshall Wace, LLP Summit Therapeutics Inc. Transaction History

Marshall Wace, LLP

  • $78.4 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.38 - $5.41 $564,189 - $2.21 Million
-408,833 Reduced 65.64%
214,033 $374,000
Q4 2022

Feb 14, 2023
BUY
$0.68 - $5.31 $327,900 - $2.56 Million
482,206 Added 342.82%
622,866 $2.65 Million
Q3 2022

Nov 14, 2022
BUY
$0.89 - $1.63 $125,187 - $229,275
140,660 New
140,660 $167,000

Others Institutions Holding SMMT

# of Institutions
231
Shares Held
83.1M
Call Options Held
1.66M
Put Options Held
2.56M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $4.95B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email